Cargando…
Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known Etiology
Lysosomal acid lipase deficiency (LAL-d) is a rare autosomal recessive disease in which LAL activity is almost absent, with consequent massive microvesicular steatosis evolving to cirrhosis and liver failure. We aimed to determine LAL-activity, and to investigate the most common single nucleotide po...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878774/ https://www.ncbi.nlm.nih.gov/pubmed/27219619 http://dx.doi.org/10.1371/journal.pone.0156113 |
_version_ | 1782433608439431168 |
---|---|
author | Vespasiani-Gentilucci, Umberto Gallo, Paolo Piemonte, Fiorella Riva, Elisabetta Porcari, Aldostefano Vorini, Ferruccio Tozzi, Giulia Piccioni, Livia Galati, Giovanni De Vincentis, Antonio Carotti, Simone Morini, Sergio D’Amico, Jessica Angeletti, Silvia Pedone, Claudio Picardi, Antonio |
author_facet | Vespasiani-Gentilucci, Umberto Gallo, Paolo Piemonte, Fiorella Riva, Elisabetta Porcari, Aldostefano Vorini, Ferruccio Tozzi, Giulia Piccioni, Livia Galati, Giovanni De Vincentis, Antonio Carotti, Simone Morini, Sergio D’Amico, Jessica Angeletti, Silvia Pedone, Claudio Picardi, Antonio |
author_sort | Vespasiani-Gentilucci, Umberto |
collection | PubMed |
description | Lysosomal acid lipase deficiency (LAL-d) is a rare autosomal recessive disease in which LAL activity is almost absent, with consequent massive microvesicular steatosis evolving to cirrhosis and liver failure. We aimed to determine LAL-activity, and to investigate the most common single nucleotide polymorphism (SNP) affecting the LIPA gene and responsible for 50–70% of LAL-d cases (rs116928232 c.894G>A), in patients with cryptogenic cirrhosis. Sixty-three patients with cryptogenic cirrhosis, 88 cirrhotics of known etiology, and 97 healthy subjects were enrolled. LAL-activity was determined in dried-blood-spot (DBS). The c.894G>A mutation was analyzed by pyrosequencing method in SNP mode. LAL-activity was severely reduced in patients with cryptogenic cirrhosis with respect to healthy subjects [0.62 (0.44–0.86) Vs 0.96 (0.75–1.25) nmol/spot/h, p<0.001)], but it was also reduced in known-etiology cirrhotics [0.54 (0.42–0.79) nmol/spot/h, p<0.001 Vs healthy subjects; p = 0.5 Vs cryptogenic cirrhotics]. Fourteen percent of cryptogenic cirrhotics and 20% of known-etiology cirrhotics showed a LAL-activity in the range of heterozygous carriers of LIPA gene mutations (0.15–0.40 nmol/spot/h). However, none of the subjects with reduced LAL-activity carried the c.894G>A SNP except for one patient with HCV cirrhosis. By multivariate analysis, LAL-activity was not associated with age, sex, liver enzymes, liver function or lipid parameters, while it was independently associated with white blood cell (β = 0.2; p<0.01) and platelet (β = 0.4; p<0.001) counts and with the condition of cirrhosis (β = -0.2; p = 0.04). CONCLUSION: Liver cirrhosis is characterized by a severe acquired reduction of LAL-activity, the precise causes and consequences of which need to be further addressed. DBS-determined lysosomal enzyme activities seem to be affected by white blood cell and platelet counts, and the specificity of these tests can be reduced when applied to determined populations, such as cirrhotics. |
format | Online Article Text |
id | pubmed-4878774 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-48787742016-06-09 Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known Etiology Vespasiani-Gentilucci, Umberto Gallo, Paolo Piemonte, Fiorella Riva, Elisabetta Porcari, Aldostefano Vorini, Ferruccio Tozzi, Giulia Piccioni, Livia Galati, Giovanni De Vincentis, Antonio Carotti, Simone Morini, Sergio D’Amico, Jessica Angeletti, Silvia Pedone, Claudio Picardi, Antonio PLoS One Research Article Lysosomal acid lipase deficiency (LAL-d) is a rare autosomal recessive disease in which LAL activity is almost absent, with consequent massive microvesicular steatosis evolving to cirrhosis and liver failure. We aimed to determine LAL-activity, and to investigate the most common single nucleotide polymorphism (SNP) affecting the LIPA gene and responsible for 50–70% of LAL-d cases (rs116928232 c.894G>A), in patients with cryptogenic cirrhosis. Sixty-three patients with cryptogenic cirrhosis, 88 cirrhotics of known etiology, and 97 healthy subjects were enrolled. LAL-activity was determined in dried-blood-spot (DBS). The c.894G>A mutation was analyzed by pyrosequencing method in SNP mode. LAL-activity was severely reduced in patients with cryptogenic cirrhosis with respect to healthy subjects [0.62 (0.44–0.86) Vs 0.96 (0.75–1.25) nmol/spot/h, p<0.001)], but it was also reduced in known-etiology cirrhotics [0.54 (0.42–0.79) nmol/spot/h, p<0.001 Vs healthy subjects; p = 0.5 Vs cryptogenic cirrhotics]. Fourteen percent of cryptogenic cirrhotics and 20% of known-etiology cirrhotics showed a LAL-activity in the range of heterozygous carriers of LIPA gene mutations (0.15–0.40 nmol/spot/h). However, none of the subjects with reduced LAL-activity carried the c.894G>A SNP except for one patient with HCV cirrhosis. By multivariate analysis, LAL-activity was not associated with age, sex, liver enzymes, liver function or lipid parameters, while it was independently associated with white blood cell (β = 0.2; p<0.01) and platelet (β = 0.4; p<0.001) counts and with the condition of cirrhosis (β = -0.2; p = 0.04). CONCLUSION: Liver cirrhosis is characterized by a severe acquired reduction of LAL-activity, the precise causes and consequences of which need to be further addressed. DBS-determined lysosomal enzyme activities seem to be affected by white blood cell and platelet counts, and the specificity of these tests can be reduced when applied to determined populations, such as cirrhotics. Public Library of Science 2016-05-24 /pmc/articles/PMC4878774/ /pubmed/27219619 http://dx.doi.org/10.1371/journal.pone.0156113 Text en © 2016 Vespasiani-Gentilucci et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Vespasiani-Gentilucci, Umberto Gallo, Paolo Piemonte, Fiorella Riva, Elisabetta Porcari, Aldostefano Vorini, Ferruccio Tozzi, Giulia Piccioni, Livia Galati, Giovanni De Vincentis, Antonio Carotti, Simone Morini, Sergio D’Amico, Jessica Angeletti, Silvia Pedone, Claudio Picardi, Antonio Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known Etiology |
title | Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known Etiology |
title_full | Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known Etiology |
title_fullStr | Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known Etiology |
title_full_unstemmed | Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known Etiology |
title_short | Lysosomal Acid Lipase Activity Is Reduced Both in Cryptogenic Cirrhosis and in Cirrhosis of Known Etiology |
title_sort | lysosomal acid lipase activity is reduced both in cryptogenic cirrhosis and in cirrhosis of known etiology |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878774/ https://www.ncbi.nlm.nih.gov/pubmed/27219619 http://dx.doi.org/10.1371/journal.pone.0156113 |
work_keys_str_mv | AT vespasianigentilucciumberto lysosomalacidlipaseactivityisreducedbothincryptogeniccirrhosisandincirrhosisofknownetiology AT gallopaolo lysosomalacidlipaseactivityisreducedbothincryptogeniccirrhosisandincirrhosisofknownetiology AT piemontefiorella lysosomalacidlipaseactivityisreducedbothincryptogeniccirrhosisandincirrhosisofknownetiology AT rivaelisabetta lysosomalacidlipaseactivityisreducedbothincryptogeniccirrhosisandincirrhosisofknownetiology AT porcarialdostefano lysosomalacidlipaseactivityisreducedbothincryptogeniccirrhosisandincirrhosisofknownetiology AT voriniferruccio lysosomalacidlipaseactivityisreducedbothincryptogeniccirrhosisandincirrhosisofknownetiology AT tozzigiulia lysosomalacidlipaseactivityisreducedbothincryptogeniccirrhosisandincirrhosisofknownetiology AT piccionilivia lysosomalacidlipaseactivityisreducedbothincryptogeniccirrhosisandincirrhosisofknownetiology AT galatigiovanni lysosomalacidlipaseactivityisreducedbothincryptogeniccirrhosisandincirrhosisofknownetiology AT devincentisantonio lysosomalacidlipaseactivityisreducedbothincryptogeniccirrhosisandincirrhosisofknownetiology AT carottisimone lysosomalacidlipaseactivityisreducedbothincryptogeniccirrhosisandincirrhosisofknownetiology AT morinisergio lysosomalacidlipaseactivityisreducedbothincryptogeniccirrhosisandincirrhosisofknownetiology AT damicojessica lysosomalacidlipaseactivityisreducedbothincryptogeniccirrhosisandincirrhosisofknownetiology AT angelettisilvia lysosomalacidlipaseactivityisreducedbothincryptogeniccirrhosisandincirrhosisofknownetiology AT pedoneclaudio lysosomalacidlipaseactivityisreducedbothincryptogeniccirrhosisandincirrhosisofknownetiology AT picardiantonio lysosomalacidlipaseactivityisreducedbothincryptogeniccirrhosisandincirrhosisofknownetiology |